Phase III Randomized Comparison of Postoperative Adjuvant Chemotherapy with 2-Year Oral UFT (Uracil/Tegafur) versus Six-Cycle CMF (Cyclophosphamide/Methotrexate/5-Fluorouracil) in High-risk Node-Negative Breast Cancer Patients
Open Access
- 1 January 1998
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 28 (1) , 77-80
- https://doi.org/10.1093/jjco/28.1.77
Abstract
N-SASBC-01 (National Surgical Adjuvant Study of Breast Cancer Protocol 01)Keywords
This publication has 4 references indexed in Scilit:
- Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the nishinihon cooperative study group of adjuvant chemoendocrine therapy for breast cancer (ACETBC) of JapanEuropean Journal Of Cancer, 1996
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1995
- Prophylactic oral UFT therapy for superficial bladder cancerCancer, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992